Search clinical trials for: Ramipril

Total 171 results

University of Erlangen-Nürnberg Medical School

Completed

TRENDY Follow-up: Study on Endothelial Function in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany
Mario Negri Institute for Pharmacological Research

Completed

Sevelamer in Proteinuric CKD (ANSWER)

Chronic Kidney Disease

Italy
University Magna Graecia

Completed

Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis

IGA Glomerulonephritis

Italy
University of Maryland, Baltimore
King Pharmaceuticals is now a wholly owned subsidiary of Pfizer

Terminated

Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes

Metabolic Syndrome

United States
St. John's Research Institute
Population Health Research Institute; Cadila Pharnmaceuticals

Completed

The Indian POLYCAP Study (TIPS)

Cardiovascular Diseases

India
Cardiology Research UBC

Terminated

Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD (SAFER-SCAD)

Coronary Artery Dissection, Spontaneous

Canada
Actelion

Completed

REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension (REPAIR)

Pulmonary Arterial Hypertension

United States, Israel, France, Netherlands, Malaysia, Germany, Australia, United Kingdom, Hong Kong, Italy, Russian Federation, Singapore
Pacific Pharmaceuticals

Unknown

Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension

Essential Hypertension

Korea, Republic of
University Hospital, Clermont-Ferrand
Servier; LivaNova

Completed

Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients? (HF 80)

Heart Failure

France
Menarini International Operations Luxembourg SA

Recruiting

Open-label, Multicenter, multinAtionaL, inteRventional Clinical Trial to Assess Efficacy and Safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtients (ARTEMISIA)

Hypertension

Hungary
University of Pavia

Unknown

Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria

Hypertension | Type 2 Diabetes

Italy
Sanofi

Completed

Use of Ramipril and Felodipine Combination Therapy in Hypertension: An Effectiveness Study With Local Patients in Argentina (RAFEHELP)

Hypertension

Argentina
University of Kansas Medical Center

Withdrawn

Pilot of Osanetant to Reduce Severity of Hot Flashes in Men With Adenocarcinoma of the Prostate (POSH-MAP)

Prostate Adenocarcinoma

United States
University of Kansas Medical Center

Terminated

Pilot of Osanetant to Reduce Testosterone in Men With Adenocarcinoma of the Prostate (PORT-MAP)

Prostate Adenocarcinoma

United States
Hospital Clínico Universitario de Valladolid

Active, not recruiting

Renin-angiotensin System Blockade Benefits in Clinical Evolution and Ventricular Remodeling After Transcatheter Aortic Valve Implantation (RASTAVI) (RASTAVI)

Angiotensin-Converting Enzyme Inhibitors | Transcatheter Aortic Valve Replacemen

Spain
Roxane Laboratories

Completed

Bioequivalency Study of Ramipril 10 mg Capsules Under Fed Conditions

Hypertension

United States
Gulhane School of Medicine

Completed

FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients

Diabetic Nephropathy | Proteinuria | Chronic Kidney Disease

Turkey
Sanofi

Completed

Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor

Glomerulonephritis

Hong Kong
University of Zurich
Sanofi

Completed

Ramipril in Rheumatoid Arthritis

Arthritis, Rheumatoid
Xinhua Hospital, Shanghai Jiao Tong University...

Not yet recruiting

Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants

Alport Syndrome

China
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Active, not recruiting

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

Glioblastoma | Chemoradiation | Cognitive Decline | Radiotherapy; Complications

United States, Guam
Ain Shams University

Completed

Ramipril in Pediatric Patients on Hemodialysis

Hemodialysis

Egypt
Sanofi

Completed

China Medical University Hospital (CMUH) Triapin Listing

Hypertension

Taiwan
Pharmtechnology LLC
Ligand Research, LLC

Completed

Bioequivalence Study of Two Formulations of Tablets Ramipril/Hydrochlorothiazide 10 mg/25 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Ferrer Internacional S.A.

Terminated

Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol

Elevated LDL Cholesterol

Spain
Norwegian University of Science and Technology
St. Olavs Hospital; Alesund Hospital; Namsos Hospital; Volvat Medisinsk Senter...

Recruiting

Bariatric Surgery and Pharmacokinetics of Ramipril

Obesity, Morbid

Norway
Daniel Carradice

Completed

Clinical and Cost Effectiveness of ACE Inhibitor, Ramipril, in Intermittent Claudicants

Intermittent Claudicants

United Kingdom
Seoul National University Hospital

Completed

An Open-labeled Trial of Ramipril in Patients With Migraine

Migraine With Hypertension

Korea, Republic of
Chinese University of Hong Kong

Completed

Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial

Normal Blood Pressure | Biopsy-confirmed IgA Nephropathy | Proteinuria Less Than 0.5 g Per Day | Serum Creatinine Below 120 Umol/l

Hong Kong
Sanofi

Completed

Ramipril 10 mg/Day Prevention

Atherosclerosis

Bangladesh
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation

Coronary Disease | Atherosclerosis | Vasculitis

United States
Actelion

Completed

A Study of Two Macitentan Pediatric Formulations in Healthy Adult Participants

Healthy

Belgium
Newcastle-upon-Tyne Hospitals NHS Trust

Completed

Cardiac Energetics and Function in Normal Human Ageing

Left Ventricular Function Systolic Dysfunction | Left Ventricular Function Diastolic Dysfunction | Ageing

United Kingdom
Fundación para la Investigación Biosanitaria del...

Recruiting

Cross-over Study of Coronary Risk Factors With a Polypill (POLICROSS)

Coronary Artery Disease

Spain
University of Nebraska

Recruiting

Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis

Peripheral Arterial Disease

United States
Novartis

Completed

Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg

Hypertension

China, India, Thailand
Baker Heart Research Institute

Completed

The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Quantum Genomics SA

Completed

Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction (QUORUM)

Myocardial Infarction

Poland, Germany, France, Hungary, Slovakia, Spain, United Kingdom
University of Vigo
King Pharmaceuticals is now a wholly owned subsidiary of Pfizer

Completed

Comparison of Awakening Versus Bedtime Dosing of Ramipril in Subjects With Essential Hypertension (HYCCRA)

Hypertension

Spain
Roxane Laboratories

Completed

Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions

Hypertension

United States
Sanofi

Completed

FOCUS:Focus On Coronary Unstable Syndromes

Myocardial Ischemia
University of Wisconsin, Madison

Completed

Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's (SEAIRA)

Hypertension | Alzheimer's Disease

United States
Centre Hospitalier Universitaire de Saint Etienne
Sanofi; Ministry of Health, France; LivaNova

Terminated

Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter (PREFACE)

Atrial Fibrillation | Atrial Flutter

France
Sanofi

Completed

Ramipril - Hypertension

Hypertension
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited, Under Non-Fasting Conditions

Healthy

India
Ferrer Internacional S.A.

Unknown

Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy

Hypertension

United States
University of Pavia

Unknown

Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria

Hypertension | Type 2 Diabetes Mellitus | Microalbuminuria

Italy
Weill Medical College of Cornell University

Terminated

Ramipril for the Treatment of Oligospermia

Male Infertility | Oligospermia | Asthenozoospermia | Teratospermia

United States
Novartis Pharmaceuticals

Completed

Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI (PARADISE-MI)

Acute Myocardial Infarction

China, United States, South Africa, Italy, Spain, Croatia, Czechia, Hungary, Romania, Taiwan, Belgium, Germany, Netherlands, Austria, Denmark, United Kingdom, Thailand, Argentina, Israel, Australia, Bulgaria, France, Greece, Russian Federation and more
Hospital Authority, Hong Kong

Unknown

Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria (eGFR)

Diabetes | Hypertensive Disease

China

Search clinical trials for: Ramipril

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations